If you mean VX-950 telaprivar, we will be lucky if it comes out. They started promising it in 2008. It has been in phase three for three years now. I sold my Vertex stock two years ago when they were held up by the FDA.
I sure hope so. I need my VL to go down, like bad.
I was talking on the phone with my Doctor about golf, and regenerative medicine. I asked about teleprivar and he said he wasn't holding his breath yet. You can get it in Europe.
The drug, called SPC3649, uses a new strategy to prevent the hepatitis C virus from replicating. Unlike other antivirals that target the virus itself, the new DNA-based drug targets a small RNA molecule in the liver that hepatitis C needs to replicate, the researchers explained.
By inhibiting the molecule, SPC3649 reduced hepatitis C virus levels in the liver and in the bloodstream in chimpanzees that received the highest dose by 350-fold.
Importantly, the virus showed no signs of resistance to SPC3649, developed by the Denmark-based company Santaris Pharma A/S. And levels of the virus remained low several months after the chimps had ended treatment, raising the possibility that the medicine would only need to be taken temporarily, the researchers added
I was talking on the phone with my Doctor about golf, and regenerative medicine. I asked about teleprivar and he said he wasn't holding his breath yet. You can get it in Europe.
It does weaken thought process.
The drug, called SPC3649, uses a new strategy to prevent the hepatitis C virus from replicating. Unlike other antivirals that target the virus itself, the new DNA-based drug targets a small RNA molecule in the liver that hepatitis C needs to replicate, the researchers explained.
By inhibiting the molecule, SPC3649 reduced hepatitis C virus levels in the liver and in the bloodstream in chimpanzees that received the highest dose by 350-fold.
Importantly, the virus showed no signs of resistance to SPC3649, developed by the Denmark-based company Santaris Pharma A/S. And levels of the virus remained low several months after the chimps had ended treatment, raising the possibility that the medicine would only need to be taken temporarily, the researchers added